GEV vs PANW: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and Palo Alto Networks, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
GE Vernova Inc. Β· Industrials
$951.82
+35.4% upside to fair value
Med Conviction Grade B High Quality
VS
Palo Alto Networks, Inc. Β· Technology
$374.74
-5.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
GEV has more upside to fair value (+35.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GEV PANW
Current Price $951.82 $374.74
Fair Value Estimate $1,288.67 $355.11
Upside to Fair Value +35.4% -5.2%
Market Cap $253.5B $305.4B
Forward P/E β€” β€”
EV / EBITDA 28.2x 569.8x
Price / Sales 6.1x 26.6x
Price / FCF 20.5x 64.0x
Revenue Growth YoY +21.9% +34.4%
Gross Margin 20.2% 70.4%
Operating Margin 4.4% 6.1%
Return on Equity 83.4% 1.7%
Dividend Yield 0.18% 0%
FCF Yield 4.88% 1.56%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
GEV β€” GE Vernova Inc.
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,…
PANW β€” Palo Alto Networks, Inc.
Palo Alto Networks is a global cybersecurity leader built around next-generation firewalls, the Panorama management platform, and a broad subscription portfolio spanning threat prevention, cloud security, secure access, and security analytics, sold to medium and large enterprises, service providers, and governments through direct and channel distribution. The business quality is genuinely high on…
Accumulation Zones
Metric GEV PANW
Zone Low $966.50 $266.33
Zone High $1,095.37 $301.84
In Buy Zone? Yes No
← GEV Research    PANW Research β†’    All Research